Linker Information

General Information of This Linker
Linker ID
LIN0WCLMP
Linker Name
Cys-11 ADC linker
Linker Type
Thiol-sensitive linker
Antibody-Linker Relation
Cleavable
Structure
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
PRO-1184 [Phase 1/2]
 ADC Info 
Identified from the Human Clinical Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Related Clinical Trial
NCT Number NCT05579366  Clinical Status Phase 1/2
Clinical Description
Phase 1/2 study of PRO1184 in patients with locally advanced and/or metastatic solid tumors.
PRO-1160 [Phase 1/2]
 ADC Info 
Identified from the Human Clinical Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [2]
Related Clinical Trial
NCT Number NCT05721222  Clinical Status Phase 1/2
Clinical Description
Phase 1/2 study of PRO1160 in patients with renal cell carcinoma (RCC), nasopharyngeal carcinoma (NPC), or non-Hodgkin lymphoma (NHL).
References
Ref 1 Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors, NCT05579366
Ref 2 Phase 1/2 Study of PRO1160 in Patients With Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma (NPC), or Non-Hodgkin Lymphoma (NHL), NCT05721222

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.